Weis Markets Pays the Check. Just Don't Expect the Raise.

Weis Markets declared its quarterly dividend of $0.34 per share on July 16, with payment hitting accounts on August 10. The annual run rate is $1.36, which works out to roughly a 1.74% yield at the current price of about $78. The dividend has been paid for 24 consecutive years. It has also been stuck at exactly $0.34 per quarter for years now, with no increase on the table.

For the income investor, that distinction between safety and growth is everything. Weis Markets is one of the safer dividend stocks you can find in the small-cap food retail space. The question isn't whether the check arrives. It's whether you're patient enough for a yield that won't move much.

The cash-flow engine is doing the work. Weis Markets just reported Q2 2026 results yesterday - revenue of $1.28 billion, up 4.6% year over year, with comparable store sales up 2.3%. That's meaningful growth for a regional grocer operating 202 stores across Pennsylvania, Maryland, Delaware, New Jersey, New York, Virginia, and West Virginia. The business is pulling more traffic and more basket dollars.

The balance sheet doesn't look like a company that's going to cut its dividend. The current ratio sits at 204% (current assets to current liabilities, a measure of short-term liquidity), meaning Weis can cover its near-term obligations twice over. Operating cash flow for the trailing twelve months is $232.6 million. Free cash flow - operating cash flow minus capital expenditures - is $22.5 million, up 575% year over year. The payout ratio is 33.7%, which means less than a third of earnings go to the dividend. That's not razor-thin coverage; that's a cushion.

Where the picture gets mixed is on the earnings side. Q2 net income actually fell 9.6% to $22.86 million, with EPS of $0.92 versus $0.96 a year ago. Pharmacy revenue was hurt by roughly $10.7 million from Inflation Reduction Act Medicare pricing provisions, which forced lower reimbursement rates on certain drugs. That headwind is structural and ongoing, not a one-off miss. Year-to-date, though, net income is still up 13.1% to $50.71 million, so the full-year trajectory hasn't been derailed.

The valuation is where Weis Markets starts to look interesting for reinvestment-minded investors. The stock trades at roughly 19 times trailing earnings and 6.7 times EV/EBITDA (enterprise value to earnings before interest, taxes, depreciation, and amortization). Compare that to Kroger, the national supermarket giant, which trades at 33.6 times trailing earnings and 8.2 times EV/EBITDA while offering a higher 2.5% dividend yield. Weis is materially cheaper on every multiple.

But here's the thing that income investors need to sit with. The dividend is flat. The market has pushed the stock up about 22% year-to-date, which compresses the yield further. At $1.36 per share, the $0.34 quarterly payment hasn't budged while the price has climbed. You're getting a safe check, but the check isn't getting bigger.

If you're using Weis Markets as a buy-and-hold for stable income, the payout is secure enough that you can sleep on it. The coverage margin is wide, the store base is growing, and the balance sheet is clean. What you won't get is dividend growth catching up to earnings power. Management has been content to let the yield drift rather than raise the quarterly amount.

The real play here is reinvestment logic, not headline yield. The stock is cheap relative to bigger grocery peers, revenue is growing, and the cash-flow engine is humming. If the income stream is still sound and the price pulls back from these levels, you can buy more units of future income for the same dollars. That's where the value accumulates - not in waiting for the dividend to rise, but in accumulating more shares at a fair price.

For a diversified income portfolio, Weis Markets plays the role of a low-volatility, low-payout-ratio holding in consumer staples. It won't be the highest-yielding name in your collection. But it's the kind of holding that keeps paying quietly while the rest of the market argues about macro, rates, and recession probabilities. That kind of steadiness is worth something when you're trying to fund a life, not trade a ticker.

Watch for two things going forward. First, whether management breaks the pattern and raises the quarterly dividend at some point - even a modest bump would signal that earnings power is translating into shareholder cash. Second, whether Inflation Reduction Act pharmacy headwinds continue to eat into margins. Both of those will tell you whether this income engine stays intact or starts showing stress.